Meridian Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
15,030
+1,194
+9% +$1.22M 0.56% 32
2026
Q1
$12.7M Buy
13,836
+18
+0.1% +$18.2K 0.45% 50
2025
Q4
$14.9M Buy
13,818
+2,685
+24% +$2.57M 0.52% 38
2025
Q3
$8.49M Buy
11,133
+1,035
+10% +$770K 0.33% 63
2025
Q2
$7.87M Buy
10,098
+325
+3% +$253K 0.34% 64
2025
Q1
$8.07M Buy
9,773
+316
+3% +$263K 0.39% 56
2024
Q4
$7.3M Buy
9,457
+418
+5% +$346K 0.35% 58
2024
Q3
$8.01M Buy
+9,039
New +$8.13M 0.39% 53
2024
Q2
Sell
-8,497
Closed -$6.61M 441
2024
Q1
$6.61M Buy
8,497
+1,580
+23% +$1.12M 1.1% 20
2023
Q4
$4.03M Sell
6,917
-3,853
-36% -$2.25M 0.26% 86
2023
Q3
$5.78M Buy
10,770
+6,759
+169% +$3.48M 0.35% 55
2023
Q2
$1.88M Buy
4,011
+967
+32% +$406K 0.16% 125
2023
Q1
$1.05M Sell
3,044
-485
-14% -$164K 0.09% 199
2022
Q4
$1.29M Buy
3,529
+76
+2% +$26.9K 0.13% 156
2022
Q3
$1.12M Sell
3,453
-425
-11% -$135K 0.12% 170
2022
Q2
$1.26M Buy
3,878
+1,450
+60% +$435K 0.1% 210
2022
Q1
$695K Buy
2,428
+734
+43% +$189K 0.08% 195
2021
Q4
$468K Buy
1,694
+154
+10% +$39K 0.05% 255
2021
Q3
$356K Sell
1,540
-235
-13% -$58K 0.04% 280
2021
Q2
$407K Sell
1,775
-876
-33% -$176K 0.05% 258
2021
Q1
$495K Buy
2,651
+764
+40% +$149K 0.07% 210
2020
Q4
$318K Buy
1,887
+53
+3% +$7.91K 0.05% 250
2020
Q3
$271K Sell
1,834
-3,455
-65% -$535K 0.07% 198
2020
Q2
$868K Buy
5,289
+1,331
+34% +$204K 0.29% 74
2020
Q1
$549K Buy
+3,958
New +$544K 0.24% 86
2019
Q3
Sell
-294
Closed -$326 359
2019
Q2
$326 Buy
+294
New +$34.6K 0.01% 447

Other funds holding LLY

Meridian Wealth Management's LLY Position: Q2 2026 in Review

Meridian Wealth Management increased its Eli Lilly (LLY) stake by 8.6% in Q2 2026, buying an estimated $1.22M and bringing the position to 15,030 shares worth $18M. The position accounts for 0.56% of the portfolio, ranked #32.

Meridian Wealth Management first reported a position in LLY in Q2 2019 and has held it in 26 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meridian Wealth Management held 15,030 shares of Eli Lilly worth $18M as of Q2 2026.
  • Meridian Wealth Management bought 1,194 Eli Lilly shares in Q2 2026, an estimated $1.22M.
  • Eli Lilly made up 0.56% of Meridian Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Meridian Wealth Management first reported a position in Eli Lilly in Q2 2019 and has held it in 26 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.